Health technology The use of inhaled nitric oxide (ino) in the treatment of neonatal respiratory failure was investigated.
|
|
- Steven Chapman
- 5 years ago
- Views:
Transcription
1 Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States Angus D C, Clermont G, Watson R S, Linde-Zwirble W T, Clark R H, Roberts M S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of inhaled nitric oxide (ino) in the treatment of neonatal respiratory failure was investigated. Type of intervention Treatment. Economic study type Cost-utility analysis. Study population The study population comprised a hypothetical cohort of term and near-term newborns with hypoxic respiratory failure. Setting The study setting was secondary care. The economic study was carried out in the USA. Dates to which data relate The effectiveness data were derived from studies dating from 1993 to The price year was Source of effectiveness data The effectiveness data were obtained from a review and synthesis of completed studies, with the authors supplementing the results from the review with their own assumptions for the reference case. Modelling The authors constructed a standard decision model for mechanically ventilated newborns with hypoxic respiratory failure. The model compared two identical cohorts, one that received no ino and one that received ino. The authors incorporated decisions about which newborns were transferred to centres providing extra corporeal membrane oxygenation (ECMO), and where ino was started. Under the base-case, the authors assumed that ino was administered to newborns only after transfer to an ECMO centre. Under the "real world" reference case, the authors assumed that ino was administered to newborns at the local hospital and not at the ECMO. This case incorporated two decisions. More specifically, the decision to transfer the infant to an ECMO centre after the initiation of ino and, if the infant was transferred, the decision to start ECMO therapy. The duration of the clinical and economic effects was modelled for one year. The outcomes included alive and healthy, alive with neurologic disability, alive with major respiratory disease, alive with both disabilities, and dead. For both the base-case and reference case, the authors used Monte Carlo simulations to generate 1,000 cohorts. Page: 1 / 7
2 Outcomes assessed in the review In the base-case, the outcomes assessed were the ECMO rate and the death rates in ECMO recipients and those not receiving ECMO. In the reference case, the outcomes assessed were the death rates in ECMO recipients and those not receiving ECMO. There were also long-term outcomes that were relevant to both cases. These outcomes were the proportion of survivors with neurodevelopmental abnormalities, the proportion of survivors with chronic pulmonary impairments, and the average utility for a survivor with any of these abnormalities. Study designs and other criteria for inclusion in the review Transition probabilities for the base-case and the proportion of individuals with any of the two abnormalities mentioned above were derived from pooling the results of two randomised controlled trials (RCTs). The average utilities were derived from a general population cohort. Sources searched to identify primary studies Not reported. Criteria used to ensure the validity of primary studies Not reported. Methods used to judge relevance and validity, and for extracting data Not reported. Number of primary studies included Approximately four primary studies were included in the review. Methods of combining primary studies Transition probabilities for the base-case were derived by pooling the results of the NINOS and CINRGI trials (see Other Publications of Related Interest). This pooling appears to have been performed in the form of a meta-analysis. Investigation of differences between primary studies The authors did not report how differences between the NINOS and CINRGI trials were investigated. However, in both these trials over 90% of newborns were transferred to ECMO centres before the study gas (ino or placebo) was initiated. Results of the review In the base-case: the ECMO rate was 38.3% (+/- 3.1) for those receiving ino and 59.3% (+/- 3.2) for those not receiving ino; in ECMO recipients, the death rate was 17.4% (+/- 4.0) for those receiving ino and 13.9% (+/- 2.9) for those not receiving ino; in those not receiving ECMO, the death rate was 6.8% (+/- 2.1) for those receiving ino and 13.1% (+/- 3.4) for those not receiving ino. In the reference case, the death rates in ECMO and non-ecmo recipients were the same as those in the base-case. The proportion of survivors with neurodevelopmental abnormalities was 35.4% (+/- 5.2) for those receiving ino and Page: 2 / 7
3 29.3% (+/- 4.9) for those not receiving ino. The average utility for these survivors was 0.7. The proportion of survivors with chronic pulmonary impairments was 13.6% (+/- 2.3) for those receiving ino and 20.0% (+/- 3.8) for those not receiving ino. The average utility for these survivors was 0.7. Methods used to derive estimates of effectiveness The authors made assumptions to supplement the results derived from the review of the literature, in order to obtain estimates for the reference case. Estimates of effectiveness and key assumptions The authors made the following assumptions. First, all newborns at local hospitals who had been transferred to an ECMO would receive ino at the hospital. For the no-ino arm, 0% of newborns received ino. Second, when ino is started at local hospitals, rapid clinical improvement would occur in the infants, thus avoiding transfer to ECMO centres. Thus, the ino transfer rate was assumed to be 100% minus the absolute reduction in ECMO by ino (21.0%), that is, 79.0%. It was assumed that the no INO transfer rate was 100%. Third, the death rate for newborns not transferred to the ECMO centre was the same as the ino arm death rate in those not receiving ECMO in the base-case (i.e. 6.8% +/- 2.1). The authors also assumed that for those not receiving ino, there were no deaths at local hospitals as all newborns were transferred. Fourth, the ECMO rate in the ino arm was equal to the base-case ECMO rate (38.3%) divided by the transfer rate (79.4%). Thus, in the reference case, the ECMO rate was assumed to be 48.2% (+/- 4.4). The no-ino arm ECMO rate was the same as that used in the base-case (59.3%) Finally, when infants suffered from both neurodevelopmental abnormalities and chronic pulmonary impairments the effect would be multiplicative. Hence, the utility associated with this health state would be 0.49 (i.e. 0.7 multiplied by 0.7). Measure of benefits used in the economic analysis The measure of benefits used was the quality-adjusted life-years (QALYs) gained. The utilities were derived from the average utility of adult patients living with chronic illness in the Beaver Dam general population cohort. Direct costs The costs and the quantities were reported separately. The direct costs of the health service and those of relatives were included in the analysis. These covered the acute care costs at both ECMO centres and local hospitals, post-discharge costs (e.g. mechanical ventilation) and transportation costs. To generate hospital costs at ECMO centres, the authors multiplied the number days at each different type of hospital ward for patients in the CINRGI trial by estimates of the daily costs. These costs were obtained from a study consisting of 260 term or near-term newborns referred to one of 4 ECMO centres. The authors multiplied all individual charges in these billing records by hospital and departmentspecific Centres for Medicare and Medicaid Services cost-to-charge ratios, then summed all costs incurred each day to generate daily costs. The authors generated separate cost estimates for the first day on ECMO and the first day on mechanical ventilation, as the initial day of invasive therapy was more expensive than subsequent days. In the reference case, for those infants not transferred to ECMO centres, the authors assumed that their hospital costs were a fraction of the costs that would have been incurred at an ECMO centre. This fraction was estimated at 0.8, following analysis of discharge abstracts of newborns in 1994 in California. The cost of ino therapy was derived from current pricing in the US market. The duration of therapy was based on patient-level observations from the CINRGI trial. Discounting was not relevant since all the costs were incurred during one year and, appropriately, it was not performed. The study reported the average costs. The price year was Page: 3 / 7
4 Statistical analysis of costs The total costs were treated stochastically. The 95% confidence ellipses around point estimates were generated using the method described by Mullahy and Manning (see Other Publications of Related Interest). Indirect Costs The indirect costs included were those due to lost wages of the infants' relatives. The sum of lost wages was calculated as the average daily wage multiplied by the total hospital length of stay, plus half-day wage multiplied by the number of outpatient visits (as obtained from Pennsylvania Medicaid claims data). The price year was Discounting was not performed because the costs were incurred during less than one year. Currency US dollars ($). Sensitivity analysis Both one-way and two-way sensitivity analyses were conducted on the reference case. The authors varied the assumptions about clinical effects, health care costs and the population treated. For the population treated, the authors explored the inclusion of two additional types of patients. More specifically, those patients not meeting the entry criteria for the clinical trials, and patients who would have met the entry criteria but never had access to ECMO centres. Estimated benefits used in the economic analysis In the base-case (where ino is initiated at ECMO centres), the number of QALYs gained per patient was 0.77 (95% confidence interval, CI: ) in the ino arm and 0.74 (95% CI: ) in the no-ino arm. This yielded an additional QALYs in the first year of life (95% CI: QALY lost to QALY gained) per treated infant. In the reference case (where ino is initiated at local hospitals), the number of QALYs gained per patient was 0.77 (95% CI: ) in the ino arm and 0.74 (95% CI: ) in the no-ino arm. This yielded an additional 0.03 QALYs (95% CI: QALYs lost to QALYs gained) at one year per treated infant. Cost results In the base-case, the mean cost per patient in the first year was $73,200 (95% CI: 69,140-77,390) in the ino arm and $75,080 (95% CI: 70,950-79,240) in the no-ino arm. This generated cost-savings of $1,880 (95% CI: $7,420 cheaper to $3,550 more expensive). In the reference case, the mean cost per patient in the first year was $75,800 (95% CI: 70,100-80,890) in the ino arm and $80,200 (95% CI: 76,200-85,000) in the no-ino arm. This generated cost-savings of $4,400 (95% CI: $11,040 cheaper to $2,410 more expensive). Synthesis of costs and benefits The costs and benefits were combined by calculating a cost-utility ratio (the additional cost required per QALY gained). Compared with no-ino therapy, ino therapy was found to be dominant (i.e. reduced health care costs and improved quality-adjusted survival) in the base-case, although there was considerable uncertainty around these means, with only 60.3% probability that ino was dominant. However, there was 84.6% probability that the incremental cost-utility ratio of using ino as opposed to not was lower than $100,000 per QALY, and only 6.3% probability that ino was dominated (i.e. higher costs and worse outcomes than a strategy of no INO). In the reference case, initiating ino at local hospitals also reduced the health care costs and improved quality-adjusted survival. Again, uncertainties around the means were considerable, with a 71.6% probability of ino being dominant, a 91.6% probability of ino having an incremental cost-utility ratio lower than $100,000 per QALY, and only 2.6% Page: 4 / 7
5 probability of it being dominated. In the reference case, the results were insensitive to the incidence of complications and their impact on quality of life. They were also insensitive to assumptions about differences in cost between local and ECMO hospitals and the impact on ECMO mortality. The results were moderately sensitive to the survival benefit of ino in newborns who did not receive ECMO, and also to including patients who would not benefit from ino. The results were sensitive to the price of the drug and hospital length of stay. Authors' conclusions Despite its high acquisition costs, inhaled nitric oxide (ino) was found to have a favourable cost-effectiveness profile for the treatment of hypoxic respiratory failure in term or near-term newborns. Under the best circumstances ino both reduced the costs and improved outcomes, independent of whether it was initiated at a local hospital before transfer or on arrival at an ECMO centre. CRD COMMENTARY - Selection of comparators No explicit justification was given for using a no-ino strategy as the comparator. The use of this comparator is justified as it was not until the end of 1999 that the US Food and Drug Administration approved ino as a treatment for severe hypoxic respiratory failure in newborns. You should decide if the comparator represents current practice in your own setting. Validity of estimate of measure of effectiveness The authors did not report the sources searched to identify the primary studies. They also failed to report whether a systematic review of the literature had been undertaken to identify relevant research and to minimise biases. However, transition probabilities for the base-case were derived from two RCTs, whose results were combined using a metaanalysis of the measures of effectiveness on 483 patients. Further, the authors reported measures of variance alongside the mean values. Despite the fact that the authors did not report how differences between the two RCTs were investigated, it would appear that both of these studies were very similar and investigated the same patient population. For the reference case, the authors supplemented the results of the review with their own assumptions. These assumptions were clearly detailed and would appear to be robust. In addition, the estimates from the review o the literature and the authors' assumptions were investigated in the sensitivity analysis. Validity of estimate of measure of benefit The estimation of benefits was modelled. The authors obtained utility values from a general population cohort. However, this study was based on utility levels of adults and it is unclear if these values can be generalised to an infant population. Validity of estimate of costs All the categories of cost relevant to the perspective adopted were included in the analysis. However, some relevant costs such as mortality costs (i.e. foregone productivity due to the infant dying) were not included in the analysis. Other costs omitted by the authors were the costs to parents associated with the care of a sick newborn (although the indirect costs of lost wages were included) and the ongoing health care costs of managing specific pulmonary or neurologic morbidities. It would appear that these omissions are likely to bias in favour of the no-ino strategy. The costs and the quantities were reported separately, which will enhance the generalisability of the authors' results to other settings. The results were derived from published studies. Sensitivity analyses on the average length of stay were conducted, using what appear to have been appropriate ranges. The unit costs were also derived from published sources and were varied in the sensitivity analysis. Medicare and Medicaid charges were used to proxy prices in some instances. Discounting was unnecessary since all the costs were incurred during one year and, therefore, was not performed. The date to which the prices related was reported, which will ease any future reflation exercises. Page: 5 / 7
6 Other issues The authors did not make appropriate comparisons of their results with the findings of similar studies. The issue of generalisability to other settings was addressed in the sensitivity analysis, although the authors warned readers that as ECMO use and cost vary substantially between the USA and other countries, the relevance of their findings to other countries remains unclear. The authors do not appear to have presented their results selectively and their conclusions reflected the scope of the analysis. The authors reported a number of further limitations to their study. First, the relatively small sample sizes of the two RCTs led to considerable uncertainty around the point estimates. However, results of the Monte Carlo simulations demonstrated that ino appeared to be favourable. Second, the time horizon was restricted to the first year of life. This conservatively assumed that all the costs and effects of ino would disappear at one year. Further research is needed to determine if ino differentially affects sequelae of severe neonatal illness. Third, quality of life was derived from an adult population since it is difficult to evaluate in infants. However, the authors' conclusions were robust to varying quality of life attributed to infants. Finally, because data on the decision-making process that leads to transfers of a newborn to an ECMO facility are lacking, the authors assumed that experienced clinicians at local hospitals would assess a newborn's responsiveness to ino and initiate transfer to an ECMO centre appropriately. Implications of the study The authors reported that ino can be disseminated into the community and used in a reasonably large proportion of all ventilated, term infants with confidence that it will be cost-effective. However, the authors warned that the costeffectiveness will degenerate if use is too indiscriminate. The authors also recommended subsequent study of the longterm effects of perinatal ino to understand fully the societal consequences of this therapy. Source of funding Supported in part by a grant from INO Therapeutics Inc., Clinton (NJ), USA. Bibliographic details Angus D C, Clermont G, Watson R S, Linde-Zwirble W T, Clark R H, Roberts M S. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics 2003; 112(6): PubMedID Other publications of related interest Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full term and nearly full term infants with hypoxic respiratory failure. New England Journal of Medicine 1997;336: Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. New England Journal of Medicine 2000;342: Javitt J, Dei CR, Chiang YP. Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity. Pediatrics 1993;91: Mullahy J, Manning WG. Statistical issues in cost-effectiveness analyses. In: Sloan F, editor. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies. New York (NY): Cambridge University Press; p Indexing Status Page: 6 / 7
7 Powered by TCPDF ( Subject indexing assigned by NLM MeSH Anoxia /economics /therapy; Cost-Benefit Analysis; Decision Trees; Extracorporeal Membrane Oxygenation /economics; Hospital Costs; Hospitals, General /economics; Hospitals, Special /economics; Humans; Infant, Newborn; Length of Stay; Monte Carlo Method; Morbidity; Nitric Oxide /administration & dosage /economics /therapeutic use; Patient Transfer /economics; Probability; Quality-Adjusted Life Years; Respiratory Insufficiency /economics /therapy; Survival Analysis; Treatment Outcome; United States; Vasodilator Agents /administration & dosage /economics /therapeutic use AccessionNumber Date bibliographic record published 30/09/2004 Date abstract record published 30/09/2004 Page: 7 / 7
Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis Tuggey J M, Plant P K, Elliott M W
Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis Tuggey J M, Plant P K, Elliott M W Record Status This is a critical abstract of an economic evaluation
More informationCost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants Suresh G K, Clark R E
Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants Suresh G K, Clark R E Record Status This is a critical abstract of an economic evaluation that meets the criteria
More informationCost effectiveness of telemedicine for the delivery of outpatient pulmonary care to a rural population Agha Z, Schapira R M, Maker A H
Cost effectiveness of telemedicine for the delivery of outpatient pulmonary care to a rural population Agha Z, Schapira R M, Maker A H Record Status This is a critical abstract of an economic evaluation
More informationType of intervention Secondary prevention of heart failure (HF)-related events in patients at risk of HF.
Emergency department observation of heart failure: preliminary analysis of safety and cost Storrow A B, Collins S P, Lyons M S, Wagoner L E, Gibler W B, Lindsell C J Record Status This is a critical abstract
More informationSetting The economic study was conducted in a large teaching hospital in Amsterdam, the Netherlands.
Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital Sevinc F, Prins J M, Koopmans R P, Langendijk P N, Bossuyt P M, Dankert J, Speelman P Record
More informationStudy population The study population comprised patients requesting same day appointments between 8:30 a.m. and 5 p.m.
Nurse telephone triage for same day appointments in general practice: multiple interrupted time series trial of effect on workload and costs Richards D A, Meakins J, Tawfik J, Godfrey L, Dutton E, Richardson
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Shifting from inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: a cost-minimization analysis Boucher M, Rodger M, Johnson J A, Tierney M Record Status This is a critical
More informationEffect of a self-management program on patients with chronic disease Lorig K R, Sobel D S, Ritter P L, Laurent D, Hobbs M
Effect of a self-management program on patients with chronic disease Lorig K R, Sobel D S, Ritter P L, Laurent D, Hobbs M Record Status This is a critical abstract of an economic evaluation that meets
More informationHospital at home or acute hospital care: a cost minimisation analysis Coast J, Richards S H, Peters T J, Gunnell D J, Darlow M, Pounsford J
Hospital at home or acute hospital care: a cost minimisation analysis Coast J, Richards S H, Peters T J, Gunnell D J, Darlow M, Pounsford J Record Status This is a critical abstract of an economic evaluation
More informationHealth technology The study examined the use of laparoscopic nephrectomy (LapDN) for living donors.
Laparoscopic vs open donor nephrectomy: a cost-utility analysis Pace K T, Dyer S J, Phan V, Stewart R J, Honey R J, Poulin E C, Schlachta C N, Mamazza J Record Status This is a critical abstract of an
More informationType of intervention Secondary prevention and treatment. Economic study type Cost-effectiveness analysis.
A comprehensive program to prevent pressure ulcers in long-term care: exploring costs and outcomes Lyder C H, Shannon R, Empleo-Frazier O, McGeHee D, White C Record Status This is a critical abstract of
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Human and financial costs of noninvasive mechanical ventilation in patients affected by COPD and acute respiratory failure Nava S, Evangelisti I, Rampulla C, Compagnoni M L, Fracchia C, Rubini F Record
More informationCase Study. Check-List for Assessing Economic Evaluations (Drummond, Chap. 3) Sample Critical Appraisal of
Case Study Work in groups At most 7-8 page, double-spaced, typed critical appraisal of a published CEA article Start with a 1-2 page summary of the article, answer the following ten questions, and then
More informationAppendix L: Economic modelling for Parkinson s disease nurse specialist care
: Economic modelling for nurse specialist care The appendix from CG35 detailing the methods and results of this analysis is reproduced verbatim in this section. No revision or updating of the analysis
More informationIntermediate care. Appendix C3: Economic report
Intermediate care Appendix C3: Economic report This report was produced by the Personal Social Services Research Unit at the London School of Economics and Political Science. PSSRU (LSE) is an independent
More informationHealth Economics: Pharmaco-economic studies
Health Economics: Pharmaco-economic studies Hans-Martin SPÄTH Département de Santé Publique Faculté de Pharmacie, Université Lyon 1 spath@univ-lyon1.fr Outline Introduction Cost data Types of economic
More informationPay-for-Performance: Approaches of Professional Societies
Pay-for-Performance: Approaches of Professional Societies CCCF 2011 Damon Scales MD PhD University of Toronto Disclosures 1.I currently hold a New Investigator Award from the Canadian Institutes for Health
More informationNursing skill mix and staffing levels for safe patient care
EVIDENCE SERVICE Providing the best available knowledge about effective care Nursing skill mix and staffing levels for safe patient care RAPID APPRAISAL OF EVIDENCE, 19 March 2015 (Style 2, v1.0) Contents
More informationEconomic report. Home haemodialysis CEP10063
Economic report Home haemodialysis CEP10063 March 2010 Contents 2 Summary... 3 Introduction... 5 Literature review... 7 Economic model... 29 Results... 44 Discussion and conclusions... 52 Acknowledgements...
More informationCardiovascular Disease Prevention and Control: Interventions Engaging Community Health Workers
Cardiovascular Disease Prevention and Control: Interventions Engaging Community Health Workers Community Preventive Services Task Force Finding and Rationale Statement Ratified March 2015 Table of Contents
More informationHigh Risk Infant Follow Up
http://www.dhcs.ca.gov/services/ccs/pages/hrif.aspx Page 1 of 9 California Children's Services Contact Us Career Opportunities He Search Home > Services > California Children's Services > Select Language
More informationEvidence based practice: Colorectal cancer nursing perspective
Evidence based practice: Colorectal cancer nursing perspective Professor Graeme D. Smith Editor Journal of Clinical Nursing Edinburgh Napier University China Medical University, August 2017 Editor JCN
More informationChapter 30 Pharmacist support
National Institute for Health and Care Excellence Final Chapter 30 Pharmacist support in over 16s: service delivery and organisation NICE guideline 94 March 2018 Developed by the National Guideline Centre,
More informationIssue date: June Guide to the methods of technology appraisal
Issue date: June 2008 Guide to the methods of technology appraisal Guide to the methods of technology appraisal Issued: June 2008 This document is one of a set that describes the process and methods that
More informationNeonatal Intensive Care Unit (NICU) Level of Care Authorization and Reimbursement Policy
In the event of conflict between a Clinical Payment and Coding Policy and any plan document under which a member is entitled to Covered Services, the plan document will govern. Plan documents include,
More informationOutline. Disproportionate Cost of Care. Health Care Costs in the US 6/1/2013. Health Care Costs
Outline Rochelle A. Dicker, MD Associate Professor of Surgery and Anesthesia UCSF Critical Care Medicine and Trauma Conference 2013 Health Care Costs Overall ICU The study of cost analysis The topics regarding
More informationClinical Practice Guideline Development Manual
Clinical Practice Guideline Development Manual Publication Date: September 2016 Review Date: September 2021 Table of Contents 1. Background... 3 2. NICE accreditation... 3 3. Patient Involvement... 3 4.
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Prestmo A, Hagen G, Sletvold O, et al. Comprehensive
More informationTITLE: Pill Splitting: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
TITLE: Pill Splitting: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines DATE: 05 June 2015 CONTEXT AND POLICY ISSUES Breaking drug tablets is a common practice referred to as pill
More informationCost Effectiveness of Physician Anesthesia J.P. Abenstein, M.S.E.E., M.D. Mayo Clinic Rochester, MN
Mayo Clinic Rochester, MN Introduction The question of whether anesthesiologists are cost-effective providers of anesthesia services remains an open question in the minds of some of our medical colleagues,
More informationOut of tariff high cost drug / technology business case template
Out of tariff high cost drug / technology business case template Out of tariff high cost drug / technology business case template Please read all the criteria before completing any of the template For
More informationFinal scope for the systematic review of the clinical and cost effectiveness evidence for the prevention of ventilator-associated pneumonia (VAP)
Final scope for the systematic review of the clinical and cost effectiveness evidence for the prevention of ventilator-associated pneumonia (VAP) Contents 1. AIM...2 2. BACKGROUND...2 3. INTERVENTIONS...3
More informationpaymentbasics The IPPS payment rates are intended to cover the costs that reasonably efficient providers would incur in furnishing highquality
Hospital ACUTE inpatient services system basics Revised: October 2015 This document does not reflect proposed legislation or regulatory actions. 425 I Street, NW Suite 701 Washington, DC 20001 ph: 202-220-3700
More informationPaediatric Critical Care and Specialised Surgery in Children Review. Paediatric critical care and ECMO: interim update
Gateway Reference: 06662 Paediatric Critical Care and Specialised Surgery in Children Review Paediatric critical care and ECMO: interim update June 2017 Contents Executive summary 1. Introduction 2. Context
More informationPrepared for North Gunther Hospital Medicare ID August 06, 2012
Prepared for North Gunther Hospital Medicare ID 000001 August 06, 2012 TABLE OF CONTENTS Introduction: Benchmarking Your Hospital 3 Section 1: Hospital Operating Costs 5 Section 2: Margins 10 Section 3:
More informationCause of death in intensive care patients within 2 years of discharge from hospital
Cause of death in intensive care patients within 2 years of discharge from hospital Peter R Hicks and Diane M Mackle Understanding of intensive care outcomes has moved from focusing on intensive care unit
More informationEconomic analysis of care pathways for Prostate Cancer follow up services
Economic analysis of care pathways for Prostate Cancer follow up services A report for Prostate Cancer UK and Transforming Cancer Services Team for London 05 February 2016 This page is intentionally blank
More informationDisposable, Non-Sterile Gloves for Minor Surgical Procedures: A Review of Clinical Evidence
CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL Disposable, Non-Sterile Gloves for Minor Surgical Procedures: A Review of Clinical Evidence Service Line: Rapid Response Service Version: 1.0
More informationDraft National Quality Assurance Criteria for Clinical Guidelines
Draft National Quality Assurance Criteria for Clinical Guidelines Consultation document July 2011 1 About the The is the independent Authority established to drive continuous improvement in Ireland s health
More informationMedicare: This subset aligns with the requirements defined by CMS and is for the review of Medicare and Medicare Advantage beneficiaries
InterQual Level of Care Criteria Subacute & SNF Criteria Review Process Introduction InterQual Level of Care Criteria support determining the appropriateness of admission, continued stay, and discharge
More informationFrequently Asked Questions (FAQ) The Harvard Pilgrim Independence Plan SM
Frequently Asked Questions (FAQ) The Harvard Pilgrim Independence Plan SM Plan Year: July 2010 June 2011 Background The Harvard Pilgrim Independence Plan was developed in 2006 for the Commonwealth of Massachusetts
More informationElsa MR Marques 1*, Ashley W. Blom 2, Erik Lenguerrand 2, Vikki Wylde 2 and Sian M. Noble 1
Marques et al. BMC Medicine (2015) 13:151 DOI 10.1186/s12916-015-0389-1 RESEARCH ARTICLE Open Access Local anaesthetic wound infiltration in addition to standard anaesthetic regimen in total hip and knee
More informationIncreased mortality associated with week-end hospital admission: a case for expanded seven-day services?
Increased mortality associated with week-end hospital admission: a case for expanded seven-day services? Nick Freemantle, 1,2 Daniel Ray, 2,3,4 David Mcnulty, 2,3 David Rosser, 5 Simon Bennett 6, Bruce
More informationOPTN/UNOS Pediatric Transplantation Committee Meeting Summary April 14, 2015 Chicago, Illiniois
OPTN/UNOS Pediatric Transplantation Committee Meeting Summary April 14, 2015 Chicago, Illiniois Eileen Brewer, MD, Chair William Mahle, MD, Vice Chair Discussions of the full committee on April 14, 2015
More informationQuality Management Building Blocks
Quality Management Building Blocks Quality Management A way of doing business that ensures continuous improvement of products and services to achieve better performance. (General Definition) Quality Management
More informationTitle:The impact of physician-nurse task-shifting in primary care on the course of disease: a systematic review
Author's response to reviews Title:The impact of physician-nurse task-shifting in primary care on the course of disease: a systematic review Authors: Nahara Anani Martínez-González (Nahara.Martinez@usz.ch)
More informationCAN TELESTROKE SAVE MEDI-CAL AND MEDICARE MONEY?
CAN TELESTROKE SAVE MEDI-CAL AND MEDICARE MONEY? Modeling the Potential Savings Prepared for CENTER FOR CONNECTED HEALTH POLICY by Trisha McMahon Matthew Newman July 5, 2012 Table of Contents EXECUTIVE
More informationHIMSS ASIAPAC 11 CONFERENCE & LEADERSHIP SUMMIT SEPTEMBER 2011 MELBOURNE, AUSTRALIA
HIMSS ASIAPAC 11 CONFERENCE & LEADERSHIP SUMMIT 20 23 SEPTEMBER 2011 MELBOURNE, AUSTRALIA INTRODUCTION AND APPLICATION OF A CODING QUALITY TOOL PICQ JOE BERRY OPERATIONS AND PROJECT MANAGER, PAVILION HEALTH
More informationSystematic Review. Request for Proposal. Grant Funding Opportunity for DNP students at UMDNJ-SN
Systematic Review Request for Proposal Grant Funding Opportunity for DNP students at UMDNJ-SN Sponsored by the New Jersey Center for Evidence Based Practice At the School of Nursing University of Medicine
More informationDISTRICT BASED NORMATIVE COSTING MODEL
DISTRICT BASED NORMATIVE COSTING MODEL Oxford Policy Management, University Gadjah Mada and GTZ Team 17 th April 2009 Contents Contents... 1 1 Introduction... 2 2 Part A: Need and Demand... 3 2.1 Epidemiology
More informationEthical framework for priority setting and resource allocation
Ethical framework for priority setting and resource allocation UNIQUE REF NUMBER: CD/XX/083/V2.0 DOCUMENT STATUS: Approved - Commissioning Development Committee 16 August 2017 DATE ISSUED: August 2017
More informationInstitute of Medicine Standards for Systematic Reviews
Institute of Medicine Standards for Systematic Reviews Christopher H Schmid Tufts University ILSI 23 January 2012 Phoenix, AZ Disclosures Member of Tufts Evidence-Based Practice Center Member, External
More informationCritical Appraisal of a Therapy Paper (Randomized Controlled Trial)
Critical Appraisal of a Therapy Paper (Randomized Controlled Trial) Goal: Participants will be able to critically appraise an article addressing therapy. Objectives: 1. Learn how build a PICO question
More informationHow to Calculate CIHI s Cost of a Standard Hospital Stay Indicator
Job Aid December 2016 How to Calculate CIHI s Cost of a Standard Hospital Stay Indicator This handout is intended as a quick reference. For more detailed information on the Cost of a Standard Hospital
More informationOrganization: Adventist Healthcare Shady Grove Medical Center
Organization: Adventist Healthcare Shady Grove Medical Center Title: A Team-Based, Innovative Approach to Providing Safer Care by Reducing the Incidence of Chronic Lung Disease in the Premature Newborn
More informationChapter 39 Bed occupancy
National Institute for Health and Care Excellence Final Chapter 39 Bed occupancy Emergency and acute medical care in over 16s: service delivery and organisation NICE guideline 94 March 218 Developed by
More informationJanet E Squires 1,2*, Katrina Sullivan 2, Martin P Eccles 3, Julia Worswick 4 and Jeremy M Grimshaw 2,5
Squires et al. Implementation Science 2014, 9:152 Implementation Science SYSTEMATIC REVIEW Open Access Are multifaceted s more effective than single-component s in changing health-care professionals behaviours?
More informationExpert Rev. Pharmacoeconomics Outcomes Res. 2(1), (2002)
Expert Rev. Pharmacoeconomics Outcomes Res. 2(1), 29-33 (2002) Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation Adrienne Heerey,Bernie McGowan, Mairin
More informationLondon CCG Neurology Profile
CCG Neurology Profile November 214 Summary NHS Hammersmith And Fulham CCG Difference from Details Comments Admissions Neurology admissions per 1, 2,13 1,94 227 p.1 Emergency admissions per 1, 1,661 1,258
More informationAn Overview of NCQA Relative Resource Use Measures. Today s Agenda
An Overview of NCQA Relative Resource Use Measures Today s Agenda The need for measures of Resource Use Development and testing RRU measures Key features of NCQA RRU measures How NCQA calculates benchmarks
More informationExecutive Summary...1. Section I Introduction...3
TABLE OF CONTENTS Executive Summary...1 Section I Introduction...3 Section II Statewide Services Provided to Special Needs Children...5 Introduction... 5 Medicaid Services... 5 Children s Medical Services
More informationVJ Periyakoil Productions presents
VJ Periyakoil Productions presents Oscar thecare Cat: Advance Lessons Learned Planning Joan M. Teno, MD, MS Professor of Community Health Warrant Alpert School of Medicine at Brown University VJ Periyakoil,
More informationContinuing Certain Medicaid Options Will Increase Costs, But Benefit Recipients and the State
January 2005 Report No. 05-03 Continuing Certain Medicaid Options Will Increase Costs, But Benefit Recipients and the State at a glance Florida provides Medicaid services to several optional groups of
More information1 Associate Professor Charles Barfield, Director, Monash Newborn Dr Tony Lewis, Deputy Director, Monash Newborn... 2
Monash Newborn Meet the team Team members 1 Associate Professor Charles Barfield, Director, Monash Newborn... 2 2 Dr Tony Lewis, Deputy Director, Monash Newborn... 2 3 Dr Alice Stewart, Consultant Neonatologist,
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationCertificate of Need (CON) Review Standards for NICU Beds & Special Newborn Nursery Services Effective March 3, 2014
+ Certificate of Need (CON) Review Standards for NICU Beds & Special Newborn Nursery Services Effective March 3, 2014 Northern Michigan Perinatal Summit July 23, 2014 Tulika Bhattacharya, CON Michigan
More informationEconomic evaluations of interventions to prevent healthcare-associated infections
TECHNICAL REPORT Economic evaluations of interventions to prevent healthcare-associated infections Literature review www.ecdc.europa.eu ECDC TECHNICAL REPORT Economic evaluations of interventions to prevent
More informationNewborn Screening Programmes in the United Kingdom
Newborn Screening Programmes in the United Kingdom This paper has been developed to increase awareness with Ministers, Members of Parliament and the Department of Health of the issues surrounding the serious
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationNorthern Ireland COPD Audit
Northern Ireland COPD Audit A regional audit of chronic obstructive pulmonary disease (COPD) care September 2017 www.rqia.org.uk Assurance, Challenge and Improvement in Health and Social Care Contents
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,
More informationEuroHOPE: Hospital performance
EuroHOPE: Hospital performance Unto Häkkinen, Research Professor Centre for Health and Social Economics, CHESS National Institute for Health and Welfare, THL What and how EuroHOPE does? Applies both the
More informationA systematic review of the literature: executive summary
A systematic review of the literature: executive summary October 2008 The effectiveness of interventions for reducing ambulatory sensitive hospitalisations: a systematic review Arindam Basu David Brinson
More informationMedical technologies guidance Published: 21 March 2018 nice.org.uk/guidance/mtg37
Thopaz+ portable digital system for managing chest drains Medical technologies guidance Published: 21 March 2018 nice.org.uk/guidance/mtg37 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationAging in Place: Do Older Americans Act Title III Services Reach Those Most Likely to Enter Nursing Homes? Nursing Home Predictors
T I M E L Y I N F O R M A T I O N F R O M M A T H E M A T I C A Improving public well-being by conducting high quality, objective research and surveys JULY 2010 Number 1 Helping Vulnerable Seniors Thrive
More informationKNOWLEDGE SYNTHESIS: Literature Searches and Beyond
KNOWLEDGE SYNTHESIS: Literature Searches and Beyond Ahmed M. Abou-Setta, MD, PhD Department of Community Health Sciences & George & Fay Yee Centre for Healthcare Innovation University of Manitoba Email:
More informationManual for costing HIV facilities and services
UNAIDS REPORT I 2011 Manual for costing HIV facilities and services UNAIDS Programmatic Branch UNAIDS 20 Avenue Appia CH-1211 Geneva 27 Switzerland Acknowledgement We would like to thank the Centers for
More informationIntegrated approaches to worker health, safety and wellbeing: Review Update
Integrated approaches to worker health, safety and wellbeing: Review Update Dr Nerida Joss Samantha Blades Dr Amanda Cooklin Date: 16 December 2015 Research report #: 088.1-1215-R01 Further information
More informationThe Efficient Measurement of Resource Utilisation in. Clinical Trials in Critical Care
The Efficient Measurement of Resource Utilisation in Clinical Trials in Critical Care Anthony Peter Delaney MBBS MSc (Epidemiology) FACEM FCICM A thesis submitted in fulfilment of the requirements for
More informationEffectiveness and safety of intravenous therapy at home for children and adolescents with acute and chronic illnesses: a systematic review protocol
Effectiveness and safety of intravenous therapy at home for children and adolescents with acute and chronic illnesses: a systematic review protocol Helena Hansson 1 Anne Brødsgaard 2 1 Department of Paediatric
More informationDownloaded from:
Hogan, H; Carver, C; Zipfel, R; Hutchings, A; Welch, J; Harrison, D; Black, N (2017) Effectiveness of ways to improve detection and rescue of deteriorating patients. British journal of hospital medicine
More informationMedical technology guidance Published: 22 July 2015 nice.org.uk/guidance/mtg25
The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites Medical technology guidance Published: 22 July 2015 nice.org.uk/guidance/mtg25 NICE 2015. All rights
More informationTitle: Length of use guidelines for oxygen tubing and face mask equipment
Title: Length of use guidelines for oxygen tubing and face mask equipment Date: September 12, 2007 Context and policy issues: There is concern that oxygen tubing and face mask equipment in the ventilator
More informationPrograms and Procedures for Chronic and High Cost Conditions Related to the Early Retiree Reinsurance Program
s and Procedures for Chronic and High Cost Conditions Related to the Early Retiree Reinsurance HealthPartners Disease and Case Management programs are targeted to those who have been identified with a
More informationSummary HTA. Invasive home mechanical ventilation, mainly focused on neuromuscular disorders. HTA-Report Summary
Summary HTA HTA-Report Summary Invasive home mechanical ventilation, mainly focused on neuromuscular disorders Geiseler J, Karg O, Börger S, Becker K, Zimolong A Introduction and background The invasive
More informationA Virtual Ward to prevent readmissions after hospital discharge
A Virtual Ward to prevent readmissions after hospital discharge Irfan Dhalla MD MSc FRCPC Departments of Medicine and Health Policy, Management and Evaluation, University of Toronto Keenan Research Centre,
More informationPROSPERO International prospective register of systematic reviews: An expanding resource
PROSPERO International prospective register of systematic reviews: An expanding resource Alison Booth 1, Marc Avey 2, Rob de Vries 3, David Moher 2, Lesley Stewart 1 1, University of York, UK 2 Ottawa
More informationOXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0
OYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline 1.1 To provide guidance on the assessment and management of infants requiring oxygen therapy
More informationScottish Hospital Standardised Mortality Ratio (HSMR)
` 2016 Scottish Hospital Standardised Mortality Ratio (HSMR) Methodology & Specification Document Page 1 of 14 Document Control Version 0.1 Date Issued July 2016 Author(s) Quality Indicators Team Comments
More informationEvaluation of the Threshold Assessment Grid as a means of improving access from primary care to mental health services
Evaluation of the Threshold Assessment Grid as a means of improving access from primary care to mental health services Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation
More informationDANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017]
DANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017] A quality of care assessment comparing safety and efficacy of edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in patients
More informationDuring the one session on value based assessment (VBA), the audience heard from 3 speakers:
The chair of NICE, David Haslam, initiated the conference by focussing on the importance of NICE and other health technology assessment (HTA) bodies in terms of the need for technology appraisal in a world
More informationChapter 41 Cost-effectiveness analyses
National Institute of Health and Care Excellence Consultation Chapter Cost-effectiveness analyses Emergency and acute medical care in over s: service delivery and organisation NICE guideline July
More informationThe Mathematics of Morality in the NICU
The Mathematics of Morality in the NICU William Meadow, MD, PhD Department of Pediatrics MacLean Center for Clinical Medical Ethics The University of Chicago I have, sadly, no relevant financial relationships
More informationContinuously Measuring Patient Outcome using Variable Life-Adjusted Displays (VLAD)
Continuously Measuring Patient Outcome using Variable Life-Adjusted Displays (VLAD) Mr. Steve GILLETT Ms. Kian WONG Dr. K.H. LEE HAHO Casemix Office Acknowledgements : 1. Queensland Health Department (VLAD
More informationWritten and verbal information versus verbal information only for patients being discharged from acute hospital settings to home: systematic review
HEALTH EDUCATION RESEARCH Vol.20 no.4 2005 Theory & Practice Pages 423 429 Advance Access publication 30 November 2004 Written and verbal information versus verbal information only for patients being discharged
More informationReal World Evidence in Europe
Real World Evidence in Europe Jessamy Baird, RWE Director Madrid, 20 th October 2014. BEFORE I BEGIN; DISCLAIMERS: Dual perspective: Pharmaceutical: I work for Lilly, but this presentation represents my
More informationCan primary care reform reduce demand on hospital outpatient departments? Key messages
STUDYING HEALTH CARE ORGANISATIONS MARCH 2007 ResearchSummary Can primary care reform reduce demand on hospital outpatient departments? This research summary examines the evidence for four different approaches
More informationTrials in Primary Care: design, conduct and evaluation of complex interventions
Trials in Primary Care: design, conduct and evaluation of complex interventions Dr Gillian Lancaster Postgraduate Statistics Centre Lancaster University g.lancaster@lancs.ac.uk Centre for Excellence in
More informationCOURSE TITLES, PRE-REQUISITES, COURSE DESCRIPTIONS AND LEARNING OBJECTIVES
COURSE TITLES, PRE-REQUISITES, COURSE DESCRIPTIONS AND LEARNING OBJECTIVES NA640 Chemistry and Physics for Nurse Anesthesia - 3 Credits This course examines the principles of inorganic chemistry, organic
More information